DTE vs NAGE
DTE (DTE) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
DTE does not have a complete income-statement cache yet.
Latest reported NAGE revenue for 2024-12-31 was $99.6M. Net income was $8.6M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
DTE currently screens at market cap $0. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the DTE and NAGE stock pages for the full models.
Not investment advice.